Zeise W. Schweiggers. J. Chem. Phys 1822; 35(173): 36.
Bhat AH, Dar KB, Khan A, Alshahrani S, Alshehri SM, Ghoneim MM, Alam P, et al. Tricyclodecan-9-yl-Xantho-genate (D609): Mechanism of Action and Pharmacologi-cal Applications. Int J Mol Sci 2022; 23(6). [DOI: 10.3390/ijms23063305]
Prudence B, Claver MP, Lambert N, Simon B. Essential-ity, Fate, Ecotoxicity, and Health Effects of Xanthates and Xanthates Based-Compounds - A Review. J Geosci Envir Protect 2022; 10(12): 161-203. [DOI: 10.4236/gep.2022.1012011]
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65(1-2): 55-63.
Meng A, Luberto C, Meier P, Bai A, Yang X, Hannun YA, Zhou D. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leu-kemia cells. Exp.Cell Res. 2004; 292(2): 385-392. [DOI: 10.1016/j.yexcr.2003.10.001]
Kiss Z, Crilly KS, Chung T. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609). Biochem Pharmacol 1998; 55(6): 915-918.
Liu J-J, Nilsson Å, Duan R-D. In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase. Lipids 2002; 37(5): 469-474.
Bettaieb A, Plo I, Mansat-De Mas V, Quillet-Mary A, Levade T, Laurent G, Jaffrqzou JP. Daunorubicin- and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced ceramide generation and apoptosis. Mol Pharmacol 1999; 55(1): 118-125.
Maheo K, Vibet S, Steghens JP, Dartigeas C, Lehman M, Bougnoux P, Gore J. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxida-tion. Free Radic.Biol.Med. 2005; 39(6): 742-751. [DOI: 10.1016/j.freeradbiomed.2005.04.023]
Amtmann E. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. Drugs under experimental and clinical research 1996; 22(6): 287-294.
Eurtivong C, Leung E, Sharma N, Leung IK, Reynisson
J. Phosphatidylcholine-Specific Phospholipase C as a Promising Drug Target. Molecules 2023; 28(15): 5637.[DOI: 10.1016/j.ejmech.2019.111919]
Sano A, Sano H, Iwanaga T, Tohda Y. Functional role of phosphatidylcholine-specific phospholipase C in regulat-ing leukotriene synthesis and degranulation in human eosinophils. Eur J Pharmacol 2020; 884(173353. [DOI: 10.1016/j.ejphar.2020.173353]
Sano A, Zhu X, Sano H, Muñoz NM, Boetticher E, Leff AR. Regulation of eosinophil function by phosphatidylin-ositol-specific PLC and cytosolic PLA2. Am J Physiol-Lung Cell Mol Physiol 2001; 281(4): L844-L851. [DOI: 10.1152/ajplung.2001.281.4.L844]
Larsen EC, Hatcher JF, Adibhatla RM. Effect of tricyclo-decan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose depriva-tion in PC12 cells. Neuroscience 2007; 146(3): 946-961.[DOI: 10.1016/j.neuroscience.2007.02.022]
Ng MN, Kitos TE, Cornell RB. Contribution of lipid sec-ond messengers to the regulation of phosphatidylcholine synthesis during cell cycle re-entry. Biochim Bioph Acta (BBA)-Mol Cell Biol Lipids 2004; 1686(1-2): 85-99. [DOI: 10.1016/j.bbalip.2004.09.001]
Luberto C, Hannun YA. Sphingomyelin synthase, a poten-tial regulator of intracellular levels of ceramide and diacyl-glycerol during SV40 transformation: does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J Biol Chem 1998; 273(23): 14550-14559.
Wright MM, Henneberry AL, Lagace TA, Ridgway ND, McMaster CR. Uncoupling farnesol-induced apoptosis from its inhibition of phosphatidylcholine synthesis. J Biol Chem 2001; 276(27): 25254-25261. [DOI: 10.1074/jbc.M011552200]
Antony P, Farooqui AA, Horrocks LA, Freysz L. Effect of D609 on phosphatidylcholine metabolism in the nuclei of LA-N-1 neuroblastoma cells: a key role for diacylglycerol. FEBS Lett 2001; 509(1): 115-118. [DOI: 10.1016/s0014-5793(01)03149-0]
Perry RJ, Ridgway ND. The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609. J Lipid Res 2004; 45(1): 164-173. [DOI: 10.1194/jlr.M300300-JLR200]
Gomez-Larrauri A, Das Adhikari U, Aramburu-Nuñez M, Custodia A, Ouro A. Ceramide metabolism enzymes—Therapeutic targets against cancer. Medicina 2021; 57(7):
[DOI: 10.3390/medicina57070729 ]
Chyan W, Zhang DY, Lippard SJ, Radford RJ. Reaction-based fluorescent sensor for investigating mobile Zn2+ in mitochondria of healthy versus cancerous prostate cells. Proc Nat Acad Sci USA 2014; 111(1): 143-148. [DOI: 10.1073/pnas.131058311]
Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio
M. TPEN induces apoptosis independently of zinc chelator activity in a model of acute lymphoblastic leukemia and ex vivo acute leukemia cells through oxidative stress and mitochondria caspase-3-and AIF-dependent pathways. Oxid Med Cell Longev 2012. [DOI: 10.1155/2012/313275]
Eurtivong C, Pilkington LI, van Rensburg M, White RM, Brar HK, Rees S, et al. Discovery of novel phosphati-dylcholine-specific phospholipase C drug-like inhibitors as potential anticancer agents. Eur J Med Chem 2020; 187(111919. [DOI: 10.1016/j.ejmech.2019.111919]
Iorio E, Ricci A, Bagnoli M, Pisanu ME, Castellano G, Di VM, et al. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res 2010; 70(5): 2126-2135. [DOI: 10.1158/0008-5472. CAN-09-3833]
Paris L, Podo F, Spadaro F, Abalsamo L, Pisanu ME, Ricci A, Cecchetti S, et al. Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model. Oncotarget 2017; 8(33): 55022. [DOI: 10.1186/bcr2575]
Bai A, Meier GP, Wang Y, Luberto C, Hannun YA, Zhou D. Prodrug modification increases potassium tricyclo[5.2.1.0(2,6)]-decan-8-yl dithiocarbonate (D609) chemical stability and cytotoxicity against U937 leukemia cells. J Pharmacol Exp Ther 2004; 309(3): 1051-1059.[DOI: 10.1124/jpet.103.064600]
Aggarwal BB, Sethi G, Nair A, Ichikawa H. Nuclear Fac-tor-kB: A Holy Grail in Cancer Prevention and Therapy. Curr Signal Transd Ther 2006; 1(25-52.
Ma J, Zhang X, Song Y, Qin Y, Tan Y, Zheng L, et al. D609 inhibition of phosphatidylcholine-specific phospholipase C attenuates prolonged insulin stimulation-mediated GLUT4 downregulation in 3T3-L1 adipocytes. J Physiol Biochem 2022; 78(2): 355-363. [DOI: 10.1007/s13105-
- 00872-x]
Alexanian A, Rufanova VA, Miller B, Flasch A, Roman RJ, Sorokin A. Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell prolif-eration and tumor growth. Anticancer Res 2009; 29(10): 3819-3824.
Guo M, Roman RJ, Falck JR, Edwards PA, Scicli AG. Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N’-(4-butyl-2-methylphenyl) formamidine], a selective inhibitor of CYP4A. J Phar-macol Exp Ther 2005; 315(2): 526-533. [DOI: 10.1124/jpet.105.088567]
Chen P, Guo M, Wygle D, Edwards PA, Falck JR, Roman RJ, Scicli AG. Inhibitors of Cytochrome P450 4A Sup-press Angiogenic Responses. Am J Pathol 2005; 166(2):
- 624. [DOI: 10.1016/S0002-9440(10)62282-1]
Michael M, Doherty MM. Tumoral drug metabolism: over-view and its implications for cancer therapy. J Clin Oncol 2005; 23(1): 205-229. [DOI: 10.1200/jco.2005.02.120]
Xu M, Ju W, Hao H, Wang G, Li P. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance. Drug Metab Rev 2013; 45(3):
- 352. [DOI: 10.3109/03602532.2013.806537]
Chan SV, Hilchie AL, Brown MG, Anderson R, Hoskin DW. Apoptosis induced by intracellular ceramide ac-cumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species. Exp Mol Pathol 2007; 82(1): 1-11. [DOI: 10.1016/j. yexmp.2006.03.001]
Chan SY, Hilchie AL, Brown MG, Anderson R, Hoskin DW. Apoptosis induced by intracellular ceramide accumu-lation in MDA-MB-435 breast carcinoma cells is depend-ent on the generation of reactive oxygen species. Exp Mol Pathol 2006. [DOI: 10.1016/j.yexmp.2006.03.001]
Nagai F, Hiyoshi Y, Sugimachi K, Tamura H-O. Cy-tochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines. Biol Pharm Bull 2002; 25(3):
- 385. [DOI: 10.1248/bpb.25.383]
Email this article (Login required) 
